Procter & Gamble vs Philip Morris International
Procter & Gamble owns some of the most entrenched consumer staples brands on the planet, from Tide to Gillette, giving it pricing power that most companies can only dream about, while Philip Morris International sells cigarettes and heated tobacco products in markets outside the United States as it navigates a slow-motion transition away from combustible tobacco. Procter & Gamble vs Philip Morris International puts two of the greatest consumer brand compounders in history side by side, both famous for reliable dividend growth and the ability to raise prices without losing customers. This comparison examines which company's product portfolio is better positioned to sustain its pricing power and cash generation over the next decade.
Procter & Gamble owns some of the most entrenched consumer staples brands on the planet, from Tide to Gillette, giving it pricing power that most companies can only dream about, while Philip Morris In...
Why It's Moving
PG Dips on Revenue Miss but Analysts Stay Bullish with Raised Targets.
- Revenue shortfall hints at softer demand in key consumer categories, pressuring near-term margins despite EPS resilience.
- JPMorgan upgraded to overweight with $165 target, while UBS boosted to $170 buy, underscoring faith in PG's market dominance.
- Insider sales by chairman (162k shares) spark caution, but moderate buy consensus and dividend stability bolster defensive appeal.
PM Stock Warning: Why Analysts See Downside Risk
- Analyst models project PM dropping to $158 by quarter-end and $144 in a year, implying significant downside from current levels around $163.
- Heavy insider sales rattled markets: CEO sold 80,000 shares for $14.57M and CFO offloaded 33,800 shares for $6.14M, cutting their stakes substantially.
- Institutional trims added pressure, with Peak Financial slashing its position by 73% and First Eagle reducing by 14%, signaling caution among big holders.
PG Dips on Revenue Miss but Analysts Stay Bullish with Raised Targets.
- Revenue shortfall hints at softer demand in key consumer categories, pressuring near-term margins despite EPS resilience.
- JPMorgan upgraded to overweight with $165 target, while UBS boosted to $170 buy, underscoring faith in PG's market dominance.
- Insider sales by chairman (162k shares) spark caution, but moderate buy consensus and dividend stability bolster defensive appeal.
PM Stock Warning: Why Analysts See Downside Risk
- Analyst models project PM dropping to $158 by quarter-end and $144 in a year, implying significant downside from current levels around $163.
- Heavy insider sales rattled markets: CEO sold 80,000 shares for $14.57M and CFO offloaded 33,800 shares for $6.14M, cutting their stakes substantially.
- Institutional trims added pressure, with Peak Financial slashing its position by 73% and First Eagle reducing by 14%, signaling caution among big holders.
Investment Analysis
Pros
- Procter & Gamble has a strong analyst consensus with a 'Buy' rating and an average price target suggesting nearly 20% upside over the next year.
- The company maintains a consistent record of dividend payments, making it attractive for income-focused investors seeking steady returns.
- Procter & Gamble operates globally with a diversified portfolio across multiple consumer product segments, supporting stable revenue streams.
Considerations
- Recent insider selling has been notable, potentially indicating concerns about future company performance among key executives.
- The current price-to-earnings ratio is relatively high, which may suggest the stock is overvalued relative to its earnings potential.
- Stock price volatility and bearish near-term sentiment create some uncertainty, with a trading range and recent lower analyst price targets indicating caution.
Pros
- Philip Morris International has shown strong market cap growth of over 27% in the past year, reflecting robust investor confidence and value creation.
- The company is actively transitioning its product portfolio towards smoke-free alternatives, aligning with evolving regulatory and consumer trends.
- Philip Morris ranks highly in several key performance and risk metrics compared to peers in the tobacco and consumer sectors.
Considerations
- Dependence on tobacco products exposes the company to regulatory risks and shifting public health policies impacting long-term growth.
- Stock price has experienced downward movement recently with some analyst caution, reflecting uncertainties in execution of portfolio transformation.
- The company's cyclicality and exposure to commodity pricing fluctuations could impact profitability under adverse market conditions.
Related Market Insights
The Recession-Proof Portfolio: Why These Stocks Thrive When Markets Crumble
Discover recession-proof stocks that thrive in economic downturns. Build a stable, defensive portfolio with essential goods companies. Invest with Nemo's curated Neme.
Aimee Silverwood | Financial Analyst
July 25, 2025
Related Market Insights
The Recession-Proof Portfolio: Why These Stocks Thrive When Markets Crumble
Discover recession-proof stocks that thrive in economic downturns. Build a stable, defensive portfolio with essential goods companies. Invest with Nemo's curated Neme.
Aimee Silverwood | Financial Analyst
July 25, 2025
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings date is April 24, 2026, before market open. This release will cover the third quarter of fiscal year 2026, following the second quarter results announced on January 22, 2026. Investors should monitor official channels for any schedule adjustments, consistent with P&G's quarterly reporting pattern.
Philip Morris International (PM) Next Earnings Date
Philip Morris International is scheduled to report its next quarterly earnings on April 22, 2026 before market open. This earnings announcement will cover the first quarter of 2026. The company has consistently reported earnings in late April following the completion of each Q1 period, making this date consistent with its historical disclosure pattern. Investors should monitor this release for updates on the company's financial performance and forward guidance.
Procter & Gamble (PG) Next Earnings Date
Procter & Gamble's next earnings date is April 24, 2026, before market open. This release will cover the third quarter of fiscal year 2026, following the second quarter results announced on January 22, 2026. Investors should monitor official channels for any schedule adjustments, consistent with P&G's quarterly reporting pattern.
Philip Morris International (PM) Next Earnings Date
Philip Morris International is scheduled to report its next quarterly earnings on April 22, 2026 before market open. This earnings announcement will cover the first quarter of 2026. The company has consistently reported earnings in late April following the completion of each Q1 period, making this date consistent with its historical disclosure pattern. Investors should monitor this release for updates on the company's financial performance and forward guidance.
Which Baskets Do They Appear In?
Top Stocks for Recessions
These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.
Published: May 3, 2025
Explore BasketWhich Baskets Do They Appear In?
Top Stocks for Recessions
These carefully selected stocks have shown remarkable resilience during economic downturns. Our team of professional analysts has identified companies that maintain stability when markets get shaky, giving you options for weathering financial storms.
Published: May 3, 2025
Explore BasketBuy PG or PM in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Procter & Gamble vs British American Tobacco
Procter & Gamble sells household and personal care brands like Tide, Gillette, and Pampers with pricing power that's held up through multiple inflation cycles, while British American Tobacco generates massive cash flows from cigarettes and is now transitioning toward reduced-risk products like vaping and heated tobacco. Both are global consumer staples giants that pay large dividends and attract income-oriented investors seeking defensive cash flow. The Procter & Gamble vs British American Tobacco comparison examines how a diversified consumer staples compounder's organic growth premium trades against a tobacco giant's deep discount valuation and transition risk.
Procter & Gamble vs Honeywell
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and commercial customers who buy on performance, not habit. Both companies are large-cap industrials-adjacent businesses with decades of dividend growth and pricing power, but their end-market dynamics differ sharply. The Procter & Gamble vs Honeywell comparison reveals how brand loyalty economics and industrial technology value propositions translate into distinctly different earnings growth trajectories.
Procter & Gamble vs General Electric
Procter and Gamble dominates household and personal care with a portfolio of branded staples sold in over 180 countries, while General Electric has reinvented itself as an aerospace-focused industrial company after decades of conglomerate sprawl. Both are blue-chip American industrials or consumer giants with long dividend histories and massive scale advantages. Procter and Gamble vs General Electric examines how a defensive consumer staples compounder stacks up against a restructured industrial cyclical, with a focus on earnings quality, margin trajectory, and which business model generates more consistent free cash flow through economic downturns.
